nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—FMO3—sweat—type 1 diabetes mellitus	0.214	0.646	CbGeAlD
Almotriptan—Parosmia—Ramipril—type 1 diabetes mellitus	0.0213	0.0434	CcSEcCtD
Almotriptan—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.0185	0.0377	CcSEcCtD
Almotriptan—MAOA—nerve—type 1 diabetes mellitus	0.0181	0.0549	CbGeAlD
Almotriptan—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.0172	0.035	CcSEcCtD
Almotriptan—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.016	0.0325	CcSEcCtD
Almotriptan—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.0134	0.0273	CcSEcCtD
Almotriptan—Neuropathy—Ramipril—type 1 diabetes mellitus	0.013	0.0264	CcSEcCtD
Almotriptan—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0113	0.023	CcSEcCtD
Almotriptan—Arthritis—Ramipril—type 1 diabetes mellitus	0.0103	0.021	CcSEcCtD
Almotriptan—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00917	0.0186	CcSEcCtD
Almotriptan—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00908	0.0184	CcSEcCtD
Almotriptan—Gastritis—Ramipril—type 1 diabetes mellitus	0.00889	0.0181	CcSEcCtD
Almotriptan—MAOA—islet of Langerhans—type 1 diabetes mellitus	0.00879	0.0266	CbGeAlD
Almotriptan—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.00862	0.0261	CbGeAlD
Almotriptan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00846	0.0172	CcSEcCtD
Almotriptan—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00846	0.0172	CcSEcCtD
Almotriptan—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.00835	0.0252	CbGeAlD
Almotriptan—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00835	0.017	CcSEcCtD
Almotriptan—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00832	0.0169	CcSEcCtD
Almotriptan—HTR1D—kidney—type 1 diabetes mellitus	0.00817	0.0247	CbGeAlD
Almotriptan—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00792	0.0161	CcSEcCtD
Almotriptan—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00763	0.0155	CcSEcCtD
Almotriptan—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00759	0.0154	CcSEcCtD
Almotriptan—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00759	0.0154	CcSEcCtD
Almotriptan—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00752	0.0153	CcSEcCtD
Almotriptan—MAOA—retina—type 1 diabetes mellitus	0.00752	0.0227	CbGeAlD
Almotriptan—Epistaxis—Ramipril—type 1 diabetes mellitus	0.0073	0.0148	CcSEcCtD
Almotriptan—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00726	0.0148	CcSEcCtD
Almotriptan—MAOA—nephron tubule—type 1 diabetes mellitus	0.00708	0.0214	CbGeAlD
Almotriptan—Visual impairment—Ramipril—type 1 diabetes mellitus	0.0067	0.0136	CcSEcCtD
Almotriptan—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00648	0.0132	CcSEcCtD
Almotriptan—MAOA—cardiovascular system—type 1 diabetes mellitus	0.00636	0.0192	CbGeAlD
Almotriptan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00628	0.0128	CcSEcCtD
Almotriptan—MAOA—kidney—type 1 diabetes mellitus	0.00622	0.0188	CbGeAlD
Almotriptan—MAOA—pancreas—type 1 diabetes mellitus	0.00618	0.0187	CbGeAlD
Almotriptan—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00609	0.0124	CcSEcCtD
Almotriptan—Erythema—Ramipril—type 1 diabetes mellitus	0.00605	0.0123	CcSEcCtD
Almotriptan—Tension—Ramipril—type 1 diabetes mellitus	0.00594	0.0121	CcSEcCtD
Almotriptan—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00592	0.012	CcSEcCtD
Almotriptan—Nervousness—Ramipril—type 1 diabetes mellitus	0.00587	0.0119	CcSEcCtD
Almotriptan—Tremor—Ramipril—type 1 diabetes mellitus	0.00567	0.0115	CcSEcCtD
Almotriptan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00561	0.0114	CcSEcCtD
Almotriptan—Agitation—Ramipril—type 1 diabetes mellitus	0.00556	0.0113	CcSEcCtD
Almotriptan—CYP2C8—kidney—type 1 diabetes mellitus	0.00555	0.0168	CbGeAlD
Almotriptan—Angioedema—Ramipril—type 1 diabetes mellitus	0.00553	0.0112	CcSEcCtD
Almotriptan—Malaise—Ramipril—type 1 diabetes mellitus	0.00545	0.0111	CcSEcCtD
Almotriptan—Vertigo—Ramipril—type 1 diabetes mellitus	0.00543	0.011	CcSEcCtD
Almotriptan—Syncope—Ramipril—type 1 diabetes mellitus	0.00542	0.011	CcSEcCtD
Almotriptan—Palpitations—Ramipril—type 1 diabetes mellitus	0.00535	0.0109	CcSEcCtD
Almotriptan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00532	0.0108	CcSEcCtD
Almotriptan—CYP2E1—nephron tubule—type 1 diabetes mellitus	0.00531	0.0161	CbGeAlD
Almotriptan—Convulsion—Ramipril—type 1 diabetes mellitus	0.00524	0.0107	CcSEcCtD
Almotriptan—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00515	0.0105	CcSEcCtD
Almotriptan—Myalgia—Ramipril—type 1 diabetes mellitus	0.00515	0.0105	CcSEcCtD
Almotriptan—Chest pain—Ramipril—type 1 diabetes mellitus	0.00515	0.0105	CcSEcCtD
Almotriptan—Anxiety—Ramipril—type 1 diabetes mellitus	0.00513	0.0104	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00511	0.0104	CcSEcCtD
Almotriptan—Discomfort—Ramipril—type 1 diabetes mellitus	0.00509	0.0103	CcSEcCtD
Almotriptan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00504	0.0102	CcSEcCtD
Almotriptan—Confusional state—Ramipril—type 1 diabetes mellitus	0.00498	0.0101	CcSEcCtD
Almotriptan—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00494	0.01	CcSEcCtD
Almotriptan—Shock—Ramipril—type 1 diabetes mellitus	0.00486	0.00987	CcSEcCtD
Almotriptan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00484	0.00984	CcSEcCtD
Almotriptan—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00482	0.00979	CcSEcCtD
Almotriptan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00479	0.00975	CcSEcCtD
Almotriptan—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00477	0.0097	CcSEcCtD
Almotriptan—CYP2E1—cardiovascular system—type 1 diabetes mellitus	0.00477	0.0144	CbGeAlD
Almotriptan—CYP2E1—kidney—type 1 diabetes mellitus	0.00467	0.0141	CbGeAlD
Almotriptan—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.0045	0.00914	CcSEcCtD
Almotriptan—Insomnia—Ramipril—type 1 diabetes mellitus	0.00446	0.00907	CcSEcCtD
Almotriptan—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00443	0.00901	CcSEcCtD
Almotriptan—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.0044	0.00894	CcSEcCtD
Almotriptan—Somnolence—Ramipril—type 1 diabetes mellitus	0.00439	0.00892	CcSEcCtD
Almotriptan—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00435	0.00883	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00426	0.00866	CcSEcCtD
Almotriptan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00426	0.00865	CcSEcCtD
Almotriptan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00407	0.00827	CcSEcCtD
Almotriptan—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00404	0.0082	CcSEcCtD
Almotriptan—CYP2E1—lymphoid tissue—type 1 diabetes mellitus	0.00401	0.0121	CbGeAlD
Almotriptan—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.0039	0.00793	CcSEcCtD
Almotriptan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.0039	0.00793	CcSEcCtD
Almotriptan—CYP3A4—kidney—type 1 diabetes mellitus	0.00376	0.0114	CbGeAlD
Almotriptan—CYP2D6—kidney—type 1 diabetes mellitus	0.0037	0.0112	CbGeAlD
Almotriptan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00364	0.00739	CcSEcCtD
Almotriptan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00354	0.0072	CcSEcCtD
Almotriptan—Pruritus—Ramipril—type 1 diabetes mellitus	0.00349	0.0071	CcSEcCtD
Almotriptan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00338	0.00686	CcSEcCtD
Almotriptan—Dizziness—Ramipril—type 1 diabetes mellitus	0.00326	0.00663	CcSEcCtD
Almotriptan—Vomiting—Ramipril—type 1 diabetes mellitus	0.00314	0.00638	CcSEcCtD
Almotriptan—Rash—Ramipril—type 1 diabetes mellitus	0.00311	0.00633	CcSEcCtD
Almotriptan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00311	0.00632	CcSEcCtD
Almotriptan—Headache—Ramipril—type 1 diabetes mellitus	0.00309	0.00629	CcSEcCtD
Almotriptan—Nausea—Ramipril—type 1 diabetes mellitus	0.00293	0.00596	CcSEcCtD
Almotriptan—HTR1B—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000334	0.00189	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000324	0.00183	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000318	0.0018	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000317	0.00179	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000316	0.00179	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000316	0.00178	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000312	0.00176	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000312	0.00176	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ITPR3—type 1 diabetes mellitus	0.00031	0.00175	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000309	0.00175	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000306	0.00173	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000294	0.00166	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000294	0.00166	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—HBA1—type 1 diabetes mellitus	0.000292	0.00165	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—APOC3—type 1 diabetes mellitus	0.00029	0.00164	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000288	0.00163	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000287	0.00162	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000287	0.00162	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000287	0.00162	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GSTT1—type 1 diabetes mellitus	0.000285	0.00161	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000284	0.0016	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000284	0.0016	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000282	0.00159	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000281	0.00159	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000281	0.00159	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000278	0.00157	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000278	0.00157	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—HBA2—type 1 diabetes mellitus	0.000273	0.00154	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000267	0.00151	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000264	0.00149	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000261	0.00147	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000258	0.00146	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—G6PC2—type 1 diabetes mellitus	0.000256	0.00145	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000247	0.00139	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000247	0.00139	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000242	0.00136	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000241	0.00136	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000239	0.00135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000234	0.00132	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GCG—type 1 diabetes mellitus	0.000227	0.00128	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000227	0.00128	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000224	0.00126	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ABCC8—type 1 diabetes mellitus	0.000222	0.00126	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000219	0.00124	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000216	0.00122	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000215	0.00122	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000215	0.00121	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000215	0.00121	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000212	0.0012	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000211	0.00119	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000209	0.00118	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000205	0.00116	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000205	0.00116	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000197	0.00111	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000196	0.0011	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000193	0.00109	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000192	0.00109	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CAT—type 1 diabetes mellitus	0.000192	0.00109	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000192	0.00108	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000189	0.00107	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000186	0.00105	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000182	0.00103	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00018	0.00102	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00018	0.00102	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000177	0.000997	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000176	0.000994	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000176	0.000992	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000175	0.000989	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000172	0.000968	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000169	0.000956	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000169	0.000952	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000169	0.000952	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000168	0.000946	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000168	0.000946	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HBA2—type 1 diabetes mellitus	0.000167	0.000945	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000166	0.000937	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000165	0.000933	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000165	0.000932	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000164	0.000926	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000164	0.000926	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000164	0.000925	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000163	0.000922	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00016	0.000905	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00016	0.000903	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000157	0.000889	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000157	0.000888	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000154	0.000871	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ITPR3—type 1 diabetes mellitus	0.000148	0.000838	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000147	0.000833	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HBA2—type 1 diabetes mellitus	0.000145	0.000817	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000141	0.000798	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—HBA1—type 1 diabetes mellitus	0.00014	0.000788	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000139	0.000787	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOC3—type 1 diabetes mellitus	0.000139	0.000784	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000138	0.000782	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000137	0.000776	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000137	0.000771	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000136	0.00077	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTT1—type 1 diabetes mellitus	0.000136	0.00077	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	0.000136	0.000768	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000135	0.00076	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000133	0.000751	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000132	0.000747	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000132	0.000747	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00013	0.000736	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000129	0.000731	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000129	0.000731	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	0.000129	0.000729	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—INS—type 1 diabetes mellitus	0.000128	0.000721	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000127	0.000715	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000125	0.000705	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000124	0.0007	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000122	0.00069	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	0.000121	0.000685	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000119	0.00067	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	0.000118	0.000666	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ALB—type 1 diabetes mellitus	0.000117	0.000661	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SST—type 1 diabetes mellitus	0.000116	0.000656	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000116	0.000653	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000115	0.000649	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000114	0.000642	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000113	0.000639	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—NOS3—type 1 diabetes mellitus	0.000112	0.000632	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000112	0.00063	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GCG—type 1 diabetes mellitus	0.000109	0.000613	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000108	0.000609	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000105	0.000594	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000103	0.000584	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000101	0.000572	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000101	0.000568	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.96e-05	0.000562	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.75e-05	0.000551	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	9.68e-05	0.000547	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.67e-05	0.000546	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.65e-05	0.000545	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.47e-05	0.000535	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	9.46e-05	0.000534	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.45e-05	0.000533	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	9.32e-05	0.000526	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CAT—type 1 diabetes mellitus	9.19e-05	0.000519	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ITPR3—type 1 diabetes mellitus	9.1e-05	0.000514	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.79e-05	0.000497	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.76e-05	0.000495	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.61e-05	0.000486	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.58e-05	0.000484	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HBA1—type 1 diabetes mellitus	8.57e-05	0.000484	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOC3—type 1 diabetes mellitus	8.51e-05	0.000481	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CD86—type 1 diabetes mellitus	8.44e-05	0.000476	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTT1—type 1 diabetes mellitus	8.36e-05	0.000472	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	8.32e-05	0.00047	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CD86—type 1 diabetes mellitus	8.26e-05	0.000466	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	8.2e-05	0.000463	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.06e-05	0.000455	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.01e-05	0.000452	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.89e-05	0.000445	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	7.87e-05	0.000444	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.84e-05	0.000443	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	7.76e-05	0.000438	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	7.65e-05	0.000432	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.61e-05	0.000429	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.48e-05	0.000422	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.45e-05	0.000421	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	7.41e-05	0.000418	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.37e-05	0.000416	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	7.36e-05	0.000416	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.33e-05	0.000414	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.32e-05	0.000413	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	7.3e-05	0.000412	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	7.23e-05	0.000408	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.22e-05	0.000408	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.17e-05	0.000405	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	7.02e-05	0.000397	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GCG—type 1 diabetes mellitus	6.66e-05	0.000376	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.66e-05	0.000376	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	6.61e-05	0.000373	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	6.57e-05	0.000371	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	6.48e-05	0.000366	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	6.46e-05	0.000365	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	6.45e-05	0.000364	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	6.33e-05	0.000357	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CD80—type 1 diabetes mellitus	6.15e-05	0.000347	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—INS—type 1 diabetes mellitus	6.1e-05	0.000345	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6.08e-05	0.000343	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	6.04e-05	0.000341	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CD80—type 1 diabetes mellitus	6.03e-05	0.00034	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.95e-05	0.000336	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	5.93e-05	0.000335	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INS—type 1 diabetes mellitus	5.81e-05	0.000328	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	5.76e-05	0.000325	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INS—type 1 diabetes mellitus	5.69e-05	0.000321	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAT—type 1 diabetes mellitus	5.64e-05	0.000318	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.62e-05	0.000318	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.6e-05	0.000316	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—type 1 diabetes mellitus	5.59e-05	0.000316	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.51e-05	0.000311	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.48e-05	0.000309	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	5.47e-05	0.000309	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—type 1 diabetes mellitus	5.35e-05	0.000302	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.2e-05	0.000293	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	5.15e-05	0.000291	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	5.14e-05	0.00029	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	5.12e-05	0.000289	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.1e-05	0.000288	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.09e-05	0.000287	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	5.03e-05	0.000284	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5e-05	0.000282	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.99e-05	0.000282	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	4.87e-05	0.000275	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	4.73e-05	0.000267	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	4.63e-05	0.000262	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	4.35e-05	0.000246	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.33e-05	0.000244	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	4.32e-05	0.000244	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.3e-05	0.000243	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.24e-05	0.000239	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.23e-05	0.000239	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.22e-05	0.000238	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.21e-05	0.000238	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	4.01e-05	0.000226	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4e-05	0.000226	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	3.97e-05	0.000224	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	3.95e-05	0.000223	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	3.88e-05	0.000219	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	3.74e-05	0.000211	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.64e-05	0.000205	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.56e-05	0.000201	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	3.43e-05	0.000194	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	3.39e-05	0.000191	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.31e-05	0.000187	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	3.28e-05	0.000185	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.24e-05	0.000183	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	3.24e-05	0.000183	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.09e-05	0.000175	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	2.97e-05	0.000167	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	2.89e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	2.84e-05	0.00016	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	2.66e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	2.65e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.62e-05	0.000148	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	2.54e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	2.53e-05	0.000143	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.49e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.44e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.33e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.25e-05	0.000127	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.06e-05	0.000116	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	1.97e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.74e-05	9.81e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.59e-05	8.99e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.52e-05	8.6e-05	CbGpPWpGaD
